Turkey: The Regulations On Pharmaceutical Product Promotion Continue To Evolve...

Last Updated: 3 April 2013
Article by Sinem Teoman

Promotion essentially means informing of healthcare professionals (physicians, pharmacists and dentists) by market authorisation holders (i.e. pharma companies) on the medical features of pharmaceutical products to enable the recipients develop sufficient technical information. Both physicians and dentists are the ones who prescribe products to patients, while pharmacists prepare and dispense such medications. Promotion is a sensitive issue, as it several important aspects including patient health, public spending, ethics & compliance and last but not least the commercial sustainability. At the end of the day, promotion is not necessary for pharma companies to better introduce their products, but also crucial for healthcare professional to keep up to date on the new treatments and the new features of the existing medications.

In Turkey, while there are some laws that have applicable provisions, the most relevant legislation on promotion is the Promotion of Pharmaceutical Products ("Promotion Regulation"). The Promotion Regulation was renewed the Ministry of Health ("MoH") and entered into force at the end of 2011. Some of its provisions will become effective in the 2013 and following years. In the meantime, in October 2012, various provisions of the Promotion Regulation were amended. MoH also published some guidelines and circulars to detail the rules of the implementation and these days the pharmaceutical industry and the other stakeholders are in the process of digesting this new legislation piece and taking their precautions to provide compliance.

Furthermore, also the pharmaceutical industry has some rules and regulations on the promotion, in particular from the perspective of ethics. Among the industry associations, the Association of Research Based Pharmaceutical Companies ("AIFD") is the professional body of the originator pharma companies, which is the Turkish extension of the European Federation of Pharmaceutical Industries and Associations ("EFPIA"). AIFD updated the Code of Good Promotional Practice and Good Communication ("AIFD Code") in light of the renewed Promotion Regulation and made it effective starting from 1st of July 2012.

Following such introduction on what has happened during the last year in the legislation and industry rules on the pharmaceutical product promotion, we would like to mention some of the significant changes introduced by such new regulations:

I. The Amendments on the Promotion Regulation

The most significant amendments can be summarised as follows:

Certification: The Document of Competency has been introduced by a definition under Article 4. With the new provision, in order to qualify as a product promotion representatives ("PPR") a certificate, which is valid for 4 years, must be obtained from the MoH. From January 1, 2015, potential PPRs are to apply for a document of competency. The minimum entry requirement for the document of competency is a high school graduation certificate and a document demonstrating successful results in the examination held by the MoH. However, university graduates of medical advertising and marketing programmes are eligible to obtain this document without any prior evaluation.

PPRs: Pharmaceutical companies shall register PPRs on the MoH's electronic record system. Furthermore, companies shall issue ID cards for their PPRs which will be mandatory to work in the field. Companies shall notify the MoH within 20 days when a PPR leaves or starts his/her work. At the beginning of the visit each PPR shall be required to display his/her ID card and to indicate which marketing authorisation holder he/ she represents to the healthcare professionals ("HCPs").

Reminder Materials: "Modest monetary value" used within the Regulation's definition of reminder materials has been determined in a more concrete way. Pursuant to this new provision, reminder materials' value cannot exceed 2.5% of the relevant year's gross minimum wage.

Educational Activities: Each HCP will be entitled to participate pharmaceutical company sponsored events for a maximum of 3 times a year, 2 of which can be sponsored by the same MA holder company. Another restriction is that HCPs can only attend only 1 event abroad.

Support: HCPs shall disclose all sorts of sponsorship received at the end of each scientific article and/or at the beginning of every speech/ presentation.

Free Samples: The quantity of free samples shall not exceed 5% of the previous year's total sale in the 1st and 2nd years and 3% of the total sales of the previous year for 3rd, 4th and 5th years and 1% thereafter.

II. The New AIFD Code

The main changes stipulated with the new Code are summarised below:

Promotion: The rule stipulates that promotion can only be aimed at healthcare professionals HCPs. It is possible to give specific information to other HCPs such as nurses and pharmacy technicians. In case of the breach of the Code, PPRs and the company will be jointly liable. It is also stipulated that pharmaceutical companies should provide service trainings to the PPRs.

Promotion Materials: The new Code abolished the positive list which was applied during 2004- 2011. However, the negative list is still applicable. Although a financial limit regarding medical scientific publications that can be distributed to HCPs is not stipulated in the law, the law states that companies should avoid extortionate payments which may lead to misinterpretation. Furthermore, the new Code stipulates detailed provisions on free samples, in parallel with the Regulation and the EFPIA Rules.

Donations: The Code states that direct or indirect donations cannot be made to HCPs. However, donations to public institutions are acceptable, provided that the conditions stipulated under the Regulation and the Code are met. The new regulation also specifies the conditions that donations can be made to non-profit organisations, institutions, and foundations that are established by the HCPs.

Educational Activities: The code states that large scale international congresses are an exception to the promotion ban concerning unlicensed pharmaceuticals. In promotions aimed at such organisations, it should be noted that such products are not licensed. As stated in the rules, large scale organisations can only be set up by specialised institutions.

Internet Usage: The Regulations also stipulated certain provisions on internet, digital platforms and social media concerning promotion of pharmaceuticals.

III. Conclusion

In light of the recent changes in Promotion Regulation and AIFD Code, it can be stated that the promotion area has become much more regulated and the official authorities have more tools to follow such activities more closely. Obviously, public has a certain level of interest that pharmaceutical product promotion activities are carried out in compliance with such regulations and ethics principles. Without doubt, the foremost benefits are the rational use of medications and access to new treatments. While the industry is working hard to improve its level of compliance with new rules, governmental agencies should also do their best in order to enable marketing authorisation holders to access HCPs and deliver their promotional messages and materials in the most appropriate way that would allow scientific content sharing.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions